Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Change in Accured Expenses (2022 - 2025)

Rxo's Change in Accured Expenses history spans 4 years, with the latest figure at $75.0 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 26.47% year-over-year to $75.0 million; the TTM value through Dec 2025 reached $2.0 million, down 98.29%, while the annual FY2025 figure was $2.0 million, 98.29% down from the prior year.
  • Change in Accured Expenses reached $75.0 million in Q4 2025 per RXO's latest filing, up from -$2.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $102.0 million in Q4 2024 to a low of -$60.0 million in Q2 2023.
  • Average Change in Accured Expenses over 4 years is $5.1 million, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Change in Accured Expenses: crashed 957.14% in 2023, then soared 2000.0% in 2024.
  • A 4-year view of Change in Accured Expenses shows it stood at -$17.0 million in 2022, then rose by 29.41% to -$12.0 million in 2023, then soared by 950.0% to $102.0 million in 2024, then dropped by 26.47% to $75.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Change in Accured Expenses are $75.0 million (Q4 2025), -$2.0 million (Q3 2025), and -$56.0 million (Q2 2025).